NSE · GAUDIUMIVF · Healthcare
Gaudium IVF and Women Health Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹22 Cr with net profit ₹8 Cr — a 34.87% net margin, versus 22.41% the period before.
Shareholding
As of 2026-06-30
- Promoter71.29%
- Public23.47%
- FII3.02%
- DII2.22%
21,910 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.36× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ESM · ESM 2. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Healthcare · ranked #30 of 79 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,28,472 Cr | 242.67 | 13.55 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,08,166 Cr | 315.74 | 10.06 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹71,876 Cr | 270.47 | 7.26 | 10.53% | 11.41% |
| Narayana Hrudayalaya Ltd. | ₹42,315 Cr | 187.89 | 9.33 | 17.76% | 10.2% |
| Aster DM Healthcare Ltd. | ₹42,227 Cr | 299.63 | 9.23 | 8.48% | 8.36% |
| Global Health Limited | ₹38,526 Cr | 267.33 | 9.72 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹31,931 Cr | 752.83 | 14.2 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,558 Cr | 239.5 | 12.58 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹17,015 Cr | 256.67 | 5.48 | 10.37% | 17.18% |
| Dr. Agarwal's Health Care Limited | ₹15,494 Cr | 391.04 | 7.65 | 6.58% | 6.4% |
| Gaudium IVF and Women Health Ltd.(this company) | ₹1,041 Cr | 106.71 | 6.83 | 16.08% | 23.48% |
AI analysis
AI-generated · google/gemini-2.5-flashGaudium IVF and Women Health Ltd. is listed on the Indian markets with a market capitalization of Rs 1077 Cr. The company reported revenue of Rs 70.96 Cr and a profit margin of 23.48%.
Positives
- +Revenue growth was 32.2%.
- +Return on capital employed (ROCE) is 20.1768%.
- +Promoter holding of 71.2922% as of June 30, 2026.
- +No promoter pledge is reported (0%).
Negatives
- −The trailing twelve-month P/E ratio is 110.46, which is higher than the EPS of Rs 3.36.
- −Promoter holding decreased from 99.9849% in September 2025 to 71.2922% in June 2026.
- −The company is under ESM 1 surveillance.
- −No dividend yield has been reported (0%).
Financial performance
Gaudium IVF and Women Health Ltd. reported revenue of Rs 70.96 Cr, indicating a revenue growth of 32.2%. The net profit for Mar 2025 was Rs 19.1274 Cr, with EBITDA at Rs 26.8134 Cr. Quarterly revenue for Mar 2026 stood at Rs 30.35 Cr, with net profit at Rs 8.36 Cr and EBITDA at Rs 11.71 Cr.
Profitability & returns
The company’s profit margin is 23.48%. Return on equity (ROE) is 16.08%, and return on capital employed (ROCE) is 20.1768%. The earnings per share (EPS) is Rs 3.36, based on the annual results for Mar 2025 where total net profit was Rs 19.1274 Cr.
Balance sheet
The debt-to-equity ratio for Gaudium IVF and Women Health Ltd. is 0.52, while the book value per share is Rs 20.92. The company has a market capitalization of Rs 1077 Cr. No dividend yield is reported for the company.
Ownership & pledges
As of June 30, 2026, promoter holding in Gaudium IVF and Women Health Ltd. was 71.2922%. Public shareholding stood at 23.4706%. FIIs held 3.0188% and DIIs held 2.2184%. The company reported no pledged promoter shares (0%).
Regulatory & surveillance
Gaudium IVF and Women Health Ltd. is currently under ESM (Enhanced Surveillance Measure) Stage 1. This includes surveillance measures such as ESM, as indicated in the provided data.
Data as of — price: 2026-07-29 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Gaudium IVF and Women Health Ltd.share price & fundamentals